Organization
Goulburn Valley Health
3 abstracts
Abstract
GUIDE: A randomized non-comparative phase II trial of biomarker-driven intermittent docetaxel versus standard-of-care docetaxel in metastatic castration-resistant prostate cancer (ANZUP 1903).Org: Australian & New Zealand Urogenital and Prostate (ANZUP) Cancer Trials Group, Chris O'Brien Lifehouse, Garvan Institute of Medical Research, Centre for Biostatistics and Clinical Trials, Peter Maccallum Cancer Centre, Centre for Biostatistics and Clinical Trials, Peter MacCallum Cancer Center,
Abstract
Real world evidence of systemic therapy in hormone receptor positive advanced breast cancer (HR+ ABC) in Australia: ARORA Registry.Org: Walter and Eliza Hall Institute of Medical Research, Eastern Health, Royal North Shore Hospital, Sydney, Australia, St Vincent's Private Hospital, The Mater Hospital Sydney,
Abstract
Awareness, preferences, and experiences of thrombosis and thromboprophylaxis in adults commencing systemic anticancer therapies: TARGET-TP trial.Org: Pharmacy Department, Peter MacCallum Cancer Centre, Melbourne, Australia, Sir Peter MacCallum Department of Oncology, University of Melbourne, Bendigo Cancer Centre, Bendigo Health, Bendigo, VIC, Australia,